delete Pharmaceutical Benefits Regulations (Amendment)
The amendment modifies the Pharmaceutical Benefits Regulations to adjust elements of the Pharmaceutical Benefits Scheme (PBS), Australia's government drug subsidy program. The changes likely involve pricing formulas, supplier obligations, and administrative processes aimed at cost containment.
The amendment entrenches a harmful regulatory intervention that distorts pharmaceutical markets, creates moral hazard, and imposes heavy compliance costs. Price controls and subsidies reduce innovation, cause supply distortions, and burden taxpayers. Unseen effects include reduced R&D investment and higher long-term prices. Affordable medicines are better achieved through free markets, not state intervention.